The total size of the dermatology devices market was USD 7,117.4 million in 2023, and it will grow at a compound annual growth rate of 12.9% by the end of this decade, to touch a value of USD 16,552.7 million by 2030.  

This is because of the growing incidence of skin ailments all over the world, rising consciousness of aesthetic procedures, mounting healthcare spending in emerging nations, and dermatology devices letting dermatologists and surgeons to identify and treat numerous skin ailments in time. 

There is a notable surge in the incidence of skin ailments at a global level recently, particularly amongst people living in regions with higher ozone exhaustion. The most common conditions are eczema, acne vulgarism, urticaria, sunburn, herpes zoster, and rosacea, contributing to the increasing acceptance of dermatology devices. 

The imaging devices category will grow at a rate of 13.3% in the years to come. This is because of the growing requirement for diagnostic devices as a result of the increasing incidence of various skin disorders and skin cancer.  

Furthermore, with the help of these 3D imaging systems, the visualization of the texture of the skin, scale, and capturing of images becomes easy for doctors to comprehend. Also, these pictures are made with the help of software that lets for the precise observation of newly developing lesions. 

Also, the rise in the incidence of product introductions and the tech progressions in imaging devices will drive the dermatology devices market growth in the years to come.  

For example, in March 2020, Lumenis Ltd. launched a cutting-edge, intelligent skincare innovation, Stellar M22. This system offers easy and quick management of tone, vascular lesions, skin texture, and removal of hair. 

In 2023, North America led the industry with a share, of 55%, in the industry. This is because of the increasing incidence of skin ailments, the growing consciousness with regards to aesthetic cosmetic surgeries, the existence of leading players, the growing healthcare spending of the government, and easy availability of cutting-edge technologies. 

Furthermore, in the U.S., over the past half a decade, about 7,000 novel incidences of self-reported skin issues have taken place every year. Amongst these, roughly 53% of contact dermatitis cases were sensitized, and 60% were as a result of irritants. Consequently, the acceptance of cutting-edge dermatology diagnostics is on the rise, and, in turn, is boosting the industry development in the nation. 

SOURCE: P&S Intelligence